Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WD-1603 Carbidopa/Levodopa ER in Early Parkinson's Disease
CTR20211904Phase 2Completed
- Sponsor
- Shanghai WD Pharmaceutical Co., Ltd.
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carbidopa + levodopa in Parkinson's disease (PD), sponsored by Shanghai WD Pharmaceutical Co., Ltd.. Started Aug 2021; status: completed.
02
Drugs
carbidopa + levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on CTR20211904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211904.